The trademark application PHELINUN was filed by ADIENNE Pharma & Biotech SA, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on March 14, 2021, and it was registered by office on June 21, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations
Pharmaceutical preparations for treatment of cancer and pharmaceutical conditioning regimen consisting of preparations for use prior to haematopoietic stem cell transplantation in haematological diseases